Calliditas Therapeutics’ nomination committee composition for the AGM 2024
It is hereby announced that Calliditas Therapeutics´s major owners have appointed a nomination committee for the AGM 2024.The nomination committee, which is appointed in accordance with the principles adopted by the extraordinary general meeting in 2017, consists of: • Patrick Sobocki, appointed by Stiftelsen Industrifonden • Karl Tobieson, appointed by Linc AB • Spike Loy, appointed by BVF • Elmar Schnee (chairman of the board of directors) The nomination committee shall, before the annual general meeting 2024, prepare a proposal for the election of chairman and other